The U.S. Food and Drug Administration has cleared for marketing a new safety engineered short-term peripheral Intra-Venous (IV) Catheter. The product, VantageCath, is designed to significantly reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets.
Existing safety engineered peripheral IVs have mechanisms to protect the [...]

Continue reading " Advantage Medical Devices Receives FDA Clearance for VantageCath "

Yulex Corporation, a company that produces natural rubber found to be safe for medical devices, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the first medical device made from guayule, a desert crop native to the U.S. Southwest.

The examination gloves made with patented Yulex(R) natural rubber, and cleared by [...]

Continue reading " FDA Clears First Medical Product Made From Yulex Natural Rubber "

ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it has received clearance from the Food and Drug Administration (FDA) to initiate clinical testing of ATI-9242, a novel antipsychotic for the treatment of schizophrenia and other psychiatric disorders. The company has begun dosing healthy volunteers with ATI-9242 in a Phase 1 safety study being conducted under an [...]

Continue reading " Novel Antipsychotic Drug for Patients with Schizophrenia "